Your browser doesn't support javascript.
loading
Designing Biodegradable Wafers Based on Poly(L-lactide-co-glycolide) and Poly(glycolide-co-ε-caprolactone) for the Prolonged and Local Release of Idarubicin for the Therapy of Glioblastoma Multiforme.
Turek, Artur; Stoklosa, Katarzyna; Borecka, Aleksandra; Paul-Samojedny, Monika; Kaczmarczyk, Bozena; Marcinkowski, Andrzej; Kasperczyk, Janusz.
Afiliación
  • Turek A; Faculty of Pharmaceutical Sciences in Sosnowiec, Medical University of Silesia, Katowice, Chair and Department of Biopharmacy, Jednosci 8, 41-200, Katowice, Poland. a.turek75@gmail.com.
  • Stoklosa K; Faculty of Pharmaceutical Sciences in Sosnowiec, Medical University of Silesia, Katowice, Chair and Department of Biopharmacy, Jednosci 8, 41-200, Katowice, Poland.
  • Borecka A; Centre of Polymer and Carbon Materials, Polish Academy of Sciences, M. Curie-Sklodowskiej 43, 41-819, Zabrze, Poland.
  • Paul-Samojedny M; Faculty of Pharmaceutical Sciences in Sosnowiec, Medical University of Silesia, Katowice, Chair and Department of Medical Genetics, Jednosci 8, 41-200, Sosnowiec, Poland.
  • Kaczmarczyk B; Centre of Polymer and Carbon Materials, Polish Academy of Sciences, M. Curie-Sklodowskiej 43, 41-819, Zabrze, Poland.
  • Marcinkowski A; Centre of Polymer and Carbon Materials, Polish Academy of Sciences, M. Curie-Sklodowskiej 43, 41-819, Zabrze, Poland.
  • Kasperczyk J; Faculty of Pharmaceutical Sciences in Sosnowiec, Medical University of Silesia, Katowice, Chair and Department of Biopharmacy, Jednosci 8, 41-200, Katowice, Poland.
Pharm Res ; 37(5): 90, 2020 May 07.
Article en En | MEDLINE | ID: mdl-32382838

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Polímeros / Portadores de Fármacos / Idarrubicina / Glioblastoma Límite: Humans Idioma: En Revista: Pharm Res Año: 2020 Tipo del documento: Article País de afiliación: Polonia Pais de publicación: Estados Unidos

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Polímeros / Portadores de Fármacos / Idarrubicina / Glioblastoma Límite: Humans Idioma: En Revista: Pharm Res Año: 2020 Tipo del documento: Article País de afiliación: Polonia Pais de publicación: Estados Unidos